Immunotherapy
News and reporting on cancer immunotherapy.
FDA Approves GlaxoSmithKline's Jemperli, Roche’s Ventana CDx for dMMR Solid Cancers
The approval expands the label for GSK's anti-PD-1 agent dostarlimab, which the FDA initially approved in April for patients with dMMR endometrial cancers.
European Consortium Nets €1M for Test to Predict Bladder Cancer Immunotherapy Response
The Eurostars grant will allow PamGene, Novigenix, and Radboud University Medical Center to develop a liquid biopsy test using mRNA and kinase activity profiling.
Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer
The Italian research group will evaluate the ability of Oncocyte's gene expression assay in samples from immunotherapy trials for advanced colorectal cancer patients.
The firm continues to pursue new applications for its multiomics machine learning technology, with recent data exploring immunotherapy response prediction.
Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay
The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow.